KAIST develops spray powder to stop bleeding in one second

Researchers at KAIST have created a spray-on powder that stops severe bleeding in about one second. The material forms a strong gel barrier on wounds and was designed with battlefield conditions in mind.

The powder, called AGCL, combines alginate, gellan gum and chitosan. When it contacts blood, it reacts with calcium ions to create a hydrogel in roughly one second. It can absorb more than seven times its weight in blood and achieves adhesive strength above 40 kPa.

Laboratory tests showed a hemolysis rate below 3 percent, cell viability above 99 percent and 99.9 percent antibacterial effect. Animal studies on liver injuries found reduced blood loss and normal liver function within two weeks, with no signs of toxicity.

The powder remained effective after two years of storage at room temperature and high humidity. PhD candidate Kyusoon Park, an Army Major, said the work began with a mission to save soldiers and expressed hope the technology will serve both defense and civilian medical needs.

The study, led by Park and Youngju Son under Professors Steve Park and Sangyong Jon, appeared online on October 28, 2025, in Advanced Functional Materials. It received the 2025 KAIST Q-Day President's Award and the Minister of National Defense Award in 2024.

Liittyvät artikkelit

Flinders University scientists in lab testing nano-cage adsorbent that removes 98% of PFAS from water, showing filtration process with molecular capture.
AI:n luoma kuva

Flinders University team reports nano-cage adsorbent that captures short-chain PFAS in water tests

Raportoinut AI AI:n luoma kuva Faktatarkistettu

Researchers at Flinders University say they have developed an adsorbent material that removed more than 98% of short- and long-chain PFAS—including hard-to-capture short-chain variants—in laboratory flow-through tests using model tap water. The approach embeds nano-sized molecular cages into mesoporous silica and, in the experiments reported, could be regenerated while remaining effective over at least five reuse cycles.

Researchers at the University of Hong Kong have developed a world-first nasal spray that delivers neurotherapeutic powder directly to the brain as first aid for ischemic stroke patients. The treatment, named NanoPowder, is designed to reduce brain damage by more than 80 per cent and improve stroke survival rates. Clinical trials are expected by 2030.

Raportoinut AI

Researchers have developed a device that filters the protein galectin-3 from the blood, showing improved survival in rat and pig models of sepsis. The approach, tested by a team in China, reduced mortality compared to controls. Human trials are planned for 2027.

Researchers at RMIT University in Australia say they have created an ultra-thin, flexible acrylic film covered with nanoscale pillars that can physically rupture viruses without relying on chemical disinfectants. In laboratory tests using human parainfluenza virus type 3, the team reported that about 94% of virus particles were damaged or destroyed within one hour.

Raportoinut AI

Researchers at Texas A&M University have shown that mammals may possess dormant abilities to regrow complex body parts. A new two-step treatment redirected healing in mice away from scarring toward tissue regeneration. The approach restored bone, joints, ligaments and tendons after amputation.

Tämä verkkosivusto käyttää evästeitä

Käytämme evästeitä analyysiä varten parantaaksemme sivustoamme. Lue tietosuojakäytäntömme tietosuojakäytäntö lisätietoja varten.
Hylkää